A team of scientists led by Nanyang Technological University, Singapore (NTU Singapore) has created a laser-powered devi...
A team of scientists at the Center for iPS Cell Research and Application (CiRA), Kyoto University in Japan, has sho...
Cerebral blood flow (CBF), which supplies oxygen and nutrients to our brain, is a crucial indicator of brain health. Inf...
Seventeen multidisciplinary research teams will each receive $5 million in funding from the Australian government to fin...
The government is boosting Australian led stem cell research through $25 million in grants, to help find and develop inn...
D&D Pharmatech Inc., a South Korea-based clinical-stage biotechnology startup focused on development and commerciali...
The increasing ageing population represents a remarked worldwide socioeconomic challenge. Pharmacological interven...
With the advent of induced pluripotent stem cell (iPSC) and embryonic stem cell (ESC) technology, regenerative stem cell...
Shanghai Public Health Clinical Centre and Cheng Kung University's Department of Microbiology and Immunology have joined...
Cell fitness has been identified as a way of predicting health outcomes in COVID-19 patients, according to a University ...
New Zealand's University of Otago researchers are behind a major scientific breakthrough which could lead to elimination...
A team of researchers at the Institute for the Advanced Study of Human Biology (ASHBi) at Kyoto University, Japan&n...
Scientists from Duke-NUS Medical School have partnered with Singapore biotechnology company Xylonix ...
Topelia Australia, a biotech company established to commercialize a novel ATT treatment for Australians in quarantine, h...
The Australian government is investing up to $30 million in health and medical research to help bring ground-breaking di...
Singapore's CellResearch Corporation (CRC) has received an ‘Innovation Passport’ for its stem cell therapy C...
A commonly available oral diuretic pill approved by the U.S. Food and Drug Administration (FDA) may be a potential candi...
HER2+ metastatic breast cancer (HER2+ mBC) is an aggressive type of breast cancer with poor prognosis. Whilst various ta...
